224 related articles for article (PubMed ID: 6365877)
1. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.
Dijkmans BA; Mattie H; Hermans J; van Furth R
J Antimicrob Chemother; 1984 Jan; 13(1):79-86. PubMed ID: 6365877
[TBL] [Abstract][Full Text] [Related]
2. Combined activity of metronidazole and gentamicin on Bacteroides fragilis in vivo and in vitro.
Dijkmans BA; Vaishnav J; Mattie H
J Antimicrob Chemother; 1985 Jan; 15(1):77-82. PubMed ID: 3882656
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
Beale AS; Gisby J
J Antimicrob Chemother; 1989 Jul; 24(1):29-37. PubMed ID: 2674099
[TBL] [Abstract][Full Text] [Related]
4. Activity of metronidazole on Bacteroides fragilis and/or Escherichia coli in vitro and in vivo.
Rylander M; Holm SE; Brorson JE; Johnsson J; Norrby R
J Antimicrob Chemother; 1981 Mar; 7(3):257-67. PubMed ID: 7024242
[No Abstract] [Full Text] [Related]
5. Bactericidal activity of metronidazole, tinidazole and ornidazole against Bacteroides fragilis in vitro.
Jokipii L; Jokipii AM
J Antimicrob Chemother; 1977 Nov; 3(6):571-7. PubMed ID: 599119
[No Abstract] [Full Text] [Related]
6. Scanning electron microscopic examination of Bacteroides fragilis and Gardnerella vaginalis after exposure to concentration gradients of metronidazole and tinidazole.
Skarin A; Mårdh PA
Scand J Infect Dis Suppl; 1981; 26():54-9. PubMed ID: 6972572
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity of tinidazole. An in vitro comparison of the effects of tinidazole and metronidazole against Bacteroides fragilis and other Anaerobic bacteria.
Jokipii AM; Jokipii L
Chemotherapy; 1977; 23(1):25-31. PubMed ID: 318974
[TBL] [Abstract][Full Text] [Related]
8. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
Brook I; Ledney GD
J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
[TBL] [Abstract][Full Text] [Related]
9. [Antibacterial and bactericidal activity of tinidazole against anaerobic bacteria comparing with metronidazole (author's transl)].
Ninomiya K; Kobata S; Imamura H; Mochizuki I; Watanabe K
Jpn J Antibiot; 1976 Mar; 29(3):325-31. PubMed ID: 1271586
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
Brook I
J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of amoxycillin/clavulanic acid in experimental Bacteroides fragilis/Escherichia coli mixed infections.
Beale AS; Gisby J; Sutherland R
J Antimicrob Chemother; 1988 Apr; 21(4):451-9. PubMed ID: 3288604
[TBL] [Abstract][Full Text] [Related]
12. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
Wells CL; Arland LA; Simmons RL; Rotstein OD
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
[TBL] [Abstract][Full Text] [Related]
13. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
[TBL] [Abstract][Full Text] [Related]
14. Cloning of a Bacteroides fragilis chromosomal determinant coding for 5-nitroimidazole resistance.
Haggoud A; Reysset G; Sebald M
FEMS Microbiol Lett; 1992 Aug; 74(1):1-5. PubMed ID: 1516803
[TBL] [Abstract][Full Text] [Related]
15. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities.
Brook I
Antimicrob Agents Chemother; 1993 May; 37(5):997-1000. PubMed ID: 8517727
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of tinidazole against anaerobes in comparison with metronidazole, ornidazole, cefoxitin and lamoxactam].
Werner H; Kuchenbecker K; Hammann R
Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6681175
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Scand J Infect Dis; 1985; 17(3):311-21. PubMed ID: 3903976
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP
Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752
[TBL] [Abstract][Full Text] [Related]
20. [Anaerobic effect of tinidazol compared with metronidazol, ornidazol, cefoxitin and lamoxactam].
Werner H; Kuchenbecker K; Hammann R
Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6676177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
